Leaflet immobility and thrombosis in transcatheter aortic valve replacement

Transcatheter aortic valve replacement (TAVR) has grown exponentially worldwide in the last decade. Due to the higher bleeding risks associated with oral anticoagulation and in patients undergoing TAVR, antiplatelet therapy is currently considered first-line antithrombotic treatment after TAVR. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Arnold C T, Holmes, David R, Mack, Michael J, Delgado, Victoria, Makkar, Raj, Blanke, Philipp, Leipsic, Jonathon A, Leon, Martin B, Bax, Jeroen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186299/
https://www.ncbi.nlm.nih.gov/pubmed/32930773
http://dx.doi.org/10.1093/eurheartj/ehaa542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186299/
https://www.ncbi.nlm.nih.gov/pubmed/32930773
http://dx.doi.org/10.1093/eurheartj/ehaa542

Ejemplares similares